A detailed history of Next Level Private LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Next Level Private LLC holds 69,106 shares of BMY stock, worth $3.52 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares
69,106
Previous 58,923 17.28%
Holding current value
$3.52 Million
Previous $3.2 Million 10.2%
% of portfolio
1.37%
Previous 1.51%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$40.25 - $52.99 $409,865 - $539,597
10,183 Added 17.28%
69,106 $2.87 Million
Q1 2024

Apr 15, 2024

BUY
$47.98 - $54.4 $33,586 - $38,080
700 Added 1.2%
58,923 $3.2 Million
Q4 2023

Jan 18, 2024

BUY
$48.48 - $57.85 $213,893 - $255,234
4,412 Added 8.2%
58,223 $2.99 Million
Q3 2023

Oct 10, 2023

SELL
$57.89 - $64.73 $15,167 - $16,959
-262 Reduced 0.48%
53,811 $3.12 Million
Q2 2023

Jul 14, 2023

BUY
$63.71 - $70.74 $96,839 - $107,524
1,520 Added 2.89%
54,073 $3.46 Million
Q1 2023

Apr 10, 2023

BUY
$65.71 - $74.53 $23,261 - $26,383
354 Added 0.68%
52,553 $3.64 Million
Q4 2022

Jan 26, 2023

BUY
$68.48 - $81.09 $2,122 - $2,513
31 Added 0.06%
52,199 $0
Q3 2022

Oct 21, 2022

BUY
$0.13 - $76.84 $6,781 - $4.01 Million
52,168 New
52,168 $3.73 Million
Q2 2022

Aug 09, 2022

SELL
$72.62 - $79.98 $3.74 Million - $4.12 Million
-51,513 Closed
0 $0
Q1 2022

May 05, 2022

BUY
$61.48 - $73.72 $32,461 - $38,924
528 Added 1.04%
51,513 $3.76 Million
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $2.73 Million - $3.19 Million
50,985 New
50,985 $3.18 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $108B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Next Level Private LLC Portfolio

Follow Next Level Private LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Next Level Private LLC, based on Form 13F filings with the SEC.

News

Stay updated on Next Level Private LLC with notifications on news.